Paul Hopper
Overview
Paul Hopper is an Australian entrepreneur and investor specializing in biotechnology and healthcare sectors. He is the Executive Chairman and founder of Chimeric Therapeutics Limited, a clinical-stage cell therapy company focused on developing CAR T cell therapies for solid tumors. Under his leadership, Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program through Phase 1/2 clinical trials, evaluating novel cell therapies for patients with neuroendocrine tumors, colorectal cancer, and gastric cancer. In August 2025, Hopper personally invested AU$800,000 in the company, demonstrating his commitment to its mission. Prior to Chimeric Therapeutics, Hopper founded and led several biotech companies. In 2015, he established Glioblast, focusing on technology licensed from Genentech for glioblastoma treatment, which was acquired by Kazia Therapeutics in 2016. He also served as Executive Chairman of Arovella Therapeutics from May 2019 to June 2022, a company specializing in drug delivery across the oral mucosa. Additionally, Hopper founded Radiopharm Theranostics in 2021 to develop radiopharmaceutical products for diagnostic and therapeutic uses. Hopper's investment philosophy centers on advancing innovative medical therapies, particularly in the oncology space. His strategic approach involves identifying and supporting early-stage companies with promising technologies, providing both financial backing and strategic guidance to drive their growth and development. This focus has contributed to the successful commercialization of several biotech ventures under his leadership.
Investment Focus
- Innovative medical therapies
- Oncology focus
- Early-stage companies
Portfolio Companies
Reach Paul Hopper directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Paul Hopper
What sectors does Paul Hopper invest in?
Paul Hopper invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Victoria, Australia. Paul Hopper is listed as a angel investor in the ConnectSafely investor database.
What stage does Paul Hopper invest at?
Paul Hopper backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 1M.
Which regions does Paul Hopper invest in?
Paul Hopper invests across United States and Australia.
What companies has Paul Hopper invested in?
Paul Hopper's portfolio includes Chimeric Therapeutics Limited, Radiopharm Theranostics, Arovella Therapeutics and Glioblast.
Last updated · Source: ConnectSafely investor database
